These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35308255)

  • 1. The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy.
    Li Z; Yang W; Yang Y; Wu J; Luo P; Liu Y
    Drug Des Devel Ther; 2022; 16():647-664. PubMed ID: 35308255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
    Du N; Xu Z; Gao M; Liu P; Sun B; Cao X
    Drug Des Devel Ther; 2018; 12():3517-3524. PubMed ID: 30425453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PAI-1 attenuates perirenal fat inflammation and the associated nephropathy in high-fat diet-induced obese mice.
    Liu Y; Wang L; Luo M; Chen N; Deng X; He J; Zhang L; Luo P; Wu J
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E260-E267. PubMed ID: 30532990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
    Pang R; Gu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y; Lin C; Ren Q; Liu Y; Yang X
    Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102).
    Qing LS; Chen TB; Sun WX; Chen L; Luo P; Zhang ZF; Ding LS
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):251-259. PubMed ID: 30315409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV Prevents Obesity-Associated Hypertension by Improving Pro-Inflammatory Reaction and Leptin Resistance.
    Jiang P; Ma D; Wang X; Wang Y; Bi Y; Yang J; Wang X; Li X
    Mol Cells; 2018 Mar; 41(3):244-255. PubMed ID: 29562733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of astragaloside IV on the expressions of transforming growth factor-β1 and thymic stromal lymphopoietin in a murine model of asthma].
    Du Q; Gu XY; Feng GZ; Shen L; Cui J; Cai JK; Huang M; Yin KS
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3139-42. PubMed ID: 22340658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
    Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of astragaloside IV on cognitive dysfunction in rats with cerebrally infarcted via TGF-β / Smad signaling pathway.
    Li L; Guo Y; Zhao Y; Wei J; Jin Y
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):87-92. PubMed ID: 32415932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway.
    Li L; Guan J; Lin R; Wang F; Ma H; Mao C; Guo X; Qu Z; Guan R
    Braz J Med Biol Res; 2023; 56():e12203. PubMed ID: 37493767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
    Gu LY; Yun-Sun ; Tang HT; Xu ZX
    J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.
    Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS
    J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats.
    Yin Y; Qi F; Song Z; Zhang B; Teng J
    Biosci Trends; 2014 Aug; 8(4):217-26. PubMed ID: 25224628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
    Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
    Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.